Reply to: Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapies
- 24 January 2023
- journal article
- letter
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 70 (5) , e30220
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Comment on: Viral infections in pediatric brain tumor patients treated with targeted therapiesPediatric Blood & Cancer, 2022
- Viral infections in pediatric brain tumor patients treated with targeted therapiesPediatric Blood & Cancer, 2022
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Intracellular signaling pathways: tyrosine kinase and mTOR inhibitors)Clinical Microbiology and Infection, 2018
- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Cell surface receptors and associated signaling pathways)Clinical Microbiology and Infection, 2018
- Attributable Risk of Infection to mTOR Inhibitors Everolimus and Temsirolimus in the Treatment of CancerCancer Investigation, 2016